Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EMA Poised To Decide On Fate Of Lilly’s Kisunla And PharmaMar’s Aplidin In EU
Jul 23 2025
•
By
Vibha Sharma
EMA’s rejection of Kisunla was out of step with the decisions of other regulatory agencies
(Shutterstock)
More from EU CHMP
More from Product Reviews